Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
about
Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activityNear-infrared laser adjuvant for influenza vaccineCAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferretsImprovement of the trivalent inactivated flu vaccine using PapMV nanoparticlesThe avian influenza vaccine Emerflu. Why did it fail?Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines.Matrix M(TM) adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4(+) T cell responses in man.Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.Development of a vaccine against pandemic influenza viruses: current status and perspectives.In Vivo Analysis of the Potency of Silicone Oil Microdroplets as Immunological Adjuvants in Protein FormulationsPreservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.Yeast Surface-Displayed H5N1 Avian Influenza Vaccines.A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines.Recombinant murine growth hormone particles are more immunogenic with intravenous than subcutaneous administrationEnhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100.Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boostingEvaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategiesBacterially produced recombinant influenza vaccines based on virus-like particles.Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection.Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau Aggregation.Bacillus amyloliquefaciens SQR9 induces dendritic cell maturation and enhances the immune response against inactivated avian influenza virus.Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virusNorovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections.Vaccine strategies to enhance immune responses in the aged.Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatmentEnzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.Induction of Dendritic Cell Maturation and Activation by a Potential Adjuvant, 2-Hydroxypropyl-β-Cyclodextrin.Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.Human influenza vaccines and assessment of immunogenicity.Return of inactivated whole-virus vaccine for superior efficacy.Synthetic adjuvants for vaccine formulations: phytol derivatives.Development of cross-protective influenza a vaccines based on cellular responses.T-cell epitope-dependent immune response in inbred (C57BL/6J, SJL/J, and C3H/HeN) and transgenic P301S and Tg2576 mice.A bursal pentapeptide (BPP-I), a novel bursal-derived peptide, exhibits antiproliferation of tumor cell and immunomodulator activity.A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant.
P2860
Q27309214-74DE2E83-C972-4789-B5EB-C4FD79FCFAD7Q28536886-3A1D417E-DB6F-41FC-A243-CFA01A9B8651Q28741710-15DDBE75-F7F8-4335-BFC2-4612BBD7DF43Q28743086-9E0E939E-9482-4313-BD06-50CFBC7D62D9Q30203302-300133CC-2110-422B-9F70-F91E03AA79A2Q30360768-4468712F-E8BF-4196-8024-6310FCA0CCC6Q30368937-D4162F12-FEC3-4309-A59C-B2F216103615Q30371866-CA7EF766-014C-4C49-9BE4-984BF8F77A0FQ30373784-DD6FF973-27ED-4395-98F8-2CC5C46D6D28Q30376902-EF950CA1-7E24-4418-A823-4B018DF0BB7EQ30386212-89E8CDBA-F731-495E-BE42-0D7E80077104Q30397351-09DB4035-B89B-4F5D-89CA-438C3508045BQ30423922-64A31DFC-64F6-416D-A996-87257F0777A9Q30586381-3A438AC4-8811-4B5A-BB52-4A3DE7774736Q33676505-8DC27B42-B241-4024-93B3-04DADFF1EAE6Q34064079-97512E00-34F9-450D-980D-E8EA4E2E931AQ34533085-07735DD6-8EE8-403C-A2E8-E1B9D43C89C7Q34555824-97685A71-BBE8-4185-AE04-D42B6F03CCE6Q34920723-D7F86043-237E-4ADF-A4B4-32DD3B61E444Q35048127-A70233CD-A5E8-4465-94C5-ECC100DEEFD7Q35070880-1BF81F2F-CA75-476D-83A0-49E2C65C8068Q35739092-241A4433-E9F9-400F-B138-9C86E4EC79C3Q35826638-7A9962F6-36C6-4571-9132-3BBF272CDDA7Q36595528-C174AF27-C628-4F69-9505-83CBD1AE16C9Q36900058-AAEFB0B8-F3B0-4D27-B9EE-F6DEE3BAC9B1Q36907013-B3995994-547A-4092-8FCC-8E180CA02E54Q37136591-35E8D75B-DD12-40F3-91D4-4682315F5227Q37179398-AC8E5806-4BAB-42D2-A893-4F4E6396C2C5Q37209757-CE160141-3468-4C8E-91A5-332449755D75Q37344582-7E0B5B28-7F3F-4018-8694-53F7265A6ED1Q37351910-8C625D5E-D1F5-4207-9B67-4E34D947CB37Q37371036-4C4D5AB6-F21D-4A80-9D41-10AE74E67EF8Q37812125-EE4BFC89-5A41-42BD-852B-A1AB2A59D6B8Q37918307-EEDB61A6-D83D-4008-B06B-1BCD8E6FE577Q38072067-A6AC6002-150B-4283-8404-AE3743E28053Q38510148-49DCDF48-7113-4C11-88B7-ADA648B5442FQ39409037-52109883-4BD3-4B86-B286-0248CE02D2C2Q39507676-736BD391-2C6A-44EA-B045-E87178869F7BQ39698048-6954BF8E-BE2F-4170-BDB4-42828747A380Q39770621-857843C7-DEC4-4A63-8F9E-9C2AFA6974FE
P2860
Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Alum boosts TH2-type antibody ...... ot confer superior protection.
@ast
Alum boosts TH2-type antibody ...... ot confer superior protection.
@en
type
label
Alum boosts TH2-type antibody ...... ot confer superior protection.
@ast
Alum boosts TH2-type antibody ...... ot confer superior protection.
@en
prefLabel
Alum boosts TH2-type antibody ...... ot confer superior protection.
@ast
Alum boosts TH2-type antibody ...... ot confer superior protection.
@en
P2093
P50
P1433
P1476
Alum boosts TH2-type antibody ...... ot confer superior protection.
@en
P2093
Jeroen Medema
Laura Bungener
Wouter Ter Veer
P304
P356
10.1016/J.VACCINE.2008.02.063
P407
P577
2008-03-18T00:00:00Z